Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury

Total Page:16

File Type:pdf, Size:1020Kb

Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury BASIC RESEARCH www.jasn.org Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury Mauro Abbate,* Carla Zoja,* Daniela Corna,* Daniela Rottoli,* Cristina Zanchi,* Nadia Azzollini,* Susanna Tomasoni,* Silvia Berlingeri,* Marina Noris,* Marina Morigi,* and Giuseppe Remuzzi*† *Mario Negri Institute for Pharmacological Research and †Unit of Nephrology and Dialysis, Azienda Ospedaliera Ospedali Riuniti di Bergamo, Bergamo, Italy ABSTRACT Intrarenal complement activation leads to chronic tubulointerstitial injury in animal models of proteinuric nephropathies, making this process a potential target for therapy. This study investigated whether a C3-mediated pathway promotes renal injury in the protein overload model and whether the abnormal exposure of proximal tubular cells to filtered complement could trigger the resulting inflammatory response. Mice with C3 deficiency were protected to a significant degree against the protein overload–induced interstitial inflammatory response and tissue damage, and they had less severe podocyte injury and less proteinuria. When the same injury was induced in wild-type (WT) mice, antiproteinuric treatment with the angiotensin-converting enzyme inhibitor lisinopril reduced the amount of plasma protein filtered, decreased the accumulation of C3 by proximal tubular cells, and protected against interstitial inflammation and damage. For determination of the injurious role of plasma-derived C3, as opposed to tubular cell–derived C3, C3-deficient kidneys were transplanted into WT mice. Protein overload led to the development of glomerular injury, accumulation of C3 in podocytes and proximal tubules, and tubulointerstitial changes. Conversely, when WT kidneys were transplanted into C3-deficient mice, protein overload led to a more mild disease and abnormal C3 deposition was not observed. These data suggest that the presence of C3 increases the glomerular filtration barrier’s susceptibility to injury, ultrafiltered C3 contributes more to tubulointerstitial damage induced by protein overload than locally synthesized C3, and local C3 synthesis is irrelevant to the development of proteinuria. It is speculated that therapies targeting complement combined with interven- tions to minimize proteinuria would more effectively prevent the progression of renal disease. J Am Soc Nephrol 19: 1158–1167, 2008. doi: 10.1681/ASN.2007060686 Chronic kidney diseases (CKD) are a major global this injury, the dysfunction of the physiologic fil- and increasing health epidemic, with expected cu- tering barrier against the loss of plasma proteins mulative costs of dialysis and kidney transplanta- into the urine may act as an independent caus- tion exceeding $1 trillion in the next decade.1 Epi- ative factor.7 Abnormally ultrafiltered proteins demiology shows tight association between CKD alter gene expression in proximal tubular cells, and cardiovascular disease, predisposition of the patients to cardiovascular events, and albuminuria Received June 20, 2007. Accepted January 11, 2008. as an independent risk factor for complications and 2–4 Published online ahead of print. Publication date available at premature death. Experimental evidence indi- www.jasn.org. cates that once diseases of various etiology destroy a Correspondence: Dr. Mauro Abbate, Mario Negri Institute for critical amount of the renal mass, injury develops in Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, remaining nephrons as a consequence of maladap- Italy. Phone: ϩ39-035-319888; Fax: ϩ39-035-319331; E-mail: tive increases in intraglomerular capillary pressure [email protected] and flow.5,6 In addition to playing a pivotal role in Copyright ᮊ 2008 by the American Society of Nephrology 1158 ISSN : 1046-6673/1906-1158 J Am Soc Nephrol 19: 1158–1167, 2008 www.jasn.org BASIC RESEARCH Figure 1. Effect of C3 deficiency on protein overload nephrop- athy in mice. (A and B) Urinary protein excretion (A) and tubular Ϫ Ϫ damage (B) in WT mice (n ϭ 5) and C3 / mice (n ϭ 5) receiving saline and in mice that were administered daily intraperitoneal Ϫ Ϫ injections of BSA (15 mg/g) for 4 wk (WT-BSA, n ϭ 9; C3 / BSA, n ϭ 7). ЊЊP Ͻ 0.01 versus WT-saline; **P Ͻ 0.01 versus WT-BSA. (C) Periodic acid-Schiff–stained sections of renal cortex of WT and Ϫ Ϫ C3 / mice given saline or BSA. Magnification, ϫ150. Figure 2. C3-dependent interstitial inflammatory and fibrogenic ϩ response to tubular protein overload. (A and B) Interstitial F4/80 ϩ Ϫ Ϫ resulting in proinflammatory and fibrogenic phenotypic cells (A) and ␣-SMA cells (B) in renal cortex of WT and C3 / changes.8 Angiotensin-converting enzyme inhibitors mice receiving saline or BSA. Data are means Ϯ SEM. ЊP Ͻ 0.05, ЊЊP Ͻ 0.01 versus WT-saline; *P Ͻ 0.05,**P Ͻ 0.01 versus (ACEi) and angiotensin receptor blockers prevent the pro- Ϫ Ϫ WT-BSA; #P Ͻ 0.01 versus C3 / saline. HPF, high-power field gressive impairment of the barrier and delay kidney failure. ϩ (ϫ400). The photomicrographs show F4/80 cells (A) and Drugs’ renoprotective effects cannot be dissociated from ϩ ␣-SMA cells (B), as revealed by immunoperoxidase and im- their action of lowering proteinuria, although they may not munofluorescence analysis, in kidney sections of WT mice Ϫ Ϫ be achieved invariably among patients. Clarifying further given saline or BSA and of a C3 / mouse given BSA. Magni- the pathophysiologic significance of the abnormal passage of fication, ϫ250. proteins to the luminal compartment of the nephron is man- datory in the search of drug targets for renal and cardiovascular protection. Complement proteins also accumulate in renal tubules of Intrarenal complement activation is a powerful mechanism of rats with protein overload proteinuria, a model in which tubulointerstitial injury by eliciting cytotoxic and proinflamma- plasma protein toxicity is specifically studied.24 ACEi treat- tory responses.9 C3 and other complement proteins were found in ment by limiting the transglomerular passage of proteins was proximal tubules in human renal biopsy material10,11 and in an effective maneuver to reduce both high protein and C3 load kidneys of rats after extensive renal mass reduction12–14 or of tubular cells in remnant kidneys14,21; however, no studies other proteinuric models.13,15–17 Protective effects of limiting tested the role of ultrafiltered complement in tubulointerstitial complement activation were revealed using C6-deficient ani- injury. Furthermore, proximal tubular cells are able to synthe- mals16,17 or genetically modified mice overexpressing a soluble size C3 and other complement factors23,25 and, in vitro, up- C3 inhibitor18 and by pharmacologic manipulations.16,17,19,20 regulate C3 in response to serum proteins,8,9 raising the possi- Stimulatory factors underlying complement-mediated injury bility that tubular C3 synthesis may be required to activate were not yet clarified. This is an important issue because com- pathogenic pathways. plement inhibitory approaches must be targeted timely and at We used C3-deficient mice and transplant experiments to specific steps. One hypothesis is that the exposure of proximal assess whether (1) protein overload proteinuria promotes re- tubular cells to excess plasma proteins as a consequence of nal injury through a C3-mediated pathway and (2) the abnor- glomerular barrier dysfunction could play a role.13,17,21,22 With mal exposure of proximal tubular cells to ultrafiltered comple- proteinuria, a key putative factor is the excess filtration of C3 ment could be a trigger of the inflammatory response. We (molecular weight 180 kD),14 the central molecule for the analyzed effects of antiproteinuric treatment with ACEi to vali- system to exert proinflammatory potential.14,23 In rats after date further the enhanced passage of proteins across the glomer- severe reduction of the renal mass, C3 was localized to prox- ular capillary barrier as a determinant of ultrafiltered protein and imal tubular cells engaged in high protein uptake.13,14,21 complement challenge of tubular cells. J Am Soc Nephrol 19: 1158–1167, 2008 Filtered Protein Toxicity via C3 1159 BASIC RESEARCH www.jasn.org droplet accumulation, cytoplasmic vacu- olization, effacement of foot processes, and formation of microvilli (Figure 3B). Podocyte damage was markedly attenu- ated in glomeruli of C3Ϫ/Ϫ BSA mice (Fig- ure 3C). Confocal microscopy showed ab- sence of C3 staining in the glomeruli of WT mice given saline (Figure 3D) and, in con- trast, C3 fixation of WT-BSA glomeruli, with a granular pattern corresponding to intracellular droplets of podocytes in the epithelial cell areas (Figure 3E). To test whether C3 deficiency may Figure 3. Podocyte injury is associated with C3 fixation in the absence of electron-dense be protective against tubulointerstitial Ϫ Ϫ immune deposits in WT mice with BSA overload and is attenuated in C3 / BSA mice. (A changes by abolishing the tubular load of through C) Electron micrographs show glomerular capillaries of WT mice given saline (A) C3 and other plasma proteins, which acts Ϫ/Ϫ or BSA (B) and of a C3 BSA mouse (C). The WT-BSA mouse glomerulus (B) shows as a trigger of tubular cell activation and podocyte swelling and protein droplets (arrows) and foot process fusion in the absence Ϫ Ϫ proinflammatory phenotypic change, we of electron-dense deposits. Podocyte changes are less marked in C3 / BSA (C). (D and performed immunohistochemical stud- E) In contrast to WT mouse given saline (D) showing only interrupted staining of Bow- man’s capsule (BC), the detection of C3 by confocal microscopy in a WT-BSA glomerulus ies for detection of filtered plasma pro- reveals C3 fixation of WT-BSA glomeruli, with a granular pattern corresponding to teins in tubular epithelial cells. In kid- intracellular droplets of podocytes in glomerular epithelial cell areas (E, arrows). Magni- neys of WT mice, C3 had peritubular fications: ϫ5600 in A through C; ϫ1000 in D and E. distribution with no apical or intracellu- lar staining (Figure 4A). In contrast, in RESULTS WT-BSA mice, C3 was detected on apical cell surface and within proximal tubular cells in addition to the normal peri- C3 Deficiency Protects Mice against Renal Damage tubular staining (Figure 4A).
Recommended publications
  • Unique Proximal Tubular Cell Injury and the Development of Acute
    Fujigaki et al. BMC Nephrology (2017) 18:339 DOI 10.1186/s12882-017-0756-6 RESEARCH ARTICLE Open Access Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome Yoshihide Fujigaki1*, Yoshifuru Tamura2, Michito Nagura2, Shigeyuki Arai2, Tatsuru Ota2, Shigeru Shibata2, Fukuo Kondo3, Yutaka Yamaguchi3 and Shunya Uchida2 Abstract Background: Adult patients with minimal change nephrotic syndrome (MCNS) are often associated with acute kidney injury (AKI). To assess the mechanisms of AKI, we examined whether tubular cell injuries unique to MCNS patients exist. Methods: We performed a retrospective analysis of clinical data and tubular cell changes using the immunohistochemical expression of vimentin as a marker of tubular injury and dedifferentiation at kidney biopsy in 37 adult MCNS patients. AKI was defined by the criteria of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines for AKI. Results: Thirteen patients (35.1%) were designated with AKI at kidney biopsy. No significant differences in age, history of hypertension, chronic kidney disease, diuretics use, proteinuria, and serum albumin were noted between the AKI and non- AKI groups. Urinary N-acetyl-β-D-glucosaminidase (uNAG) and urinary alpha1-microglobulin (uA1MG) as markers of tubular injury were increased in both groups, but the levels were significantly increased in the AKI group compared with the non- AKI group. The incidence of vimentin-positive tubules was comparable between AKI (84.6%) and non-AKI (58.3%) groups, but vimentin-positive tubular area per interstitial area was significantly increased in the AKI group (19.8%) compared with the non-AKI group (6.8%) (p = 0.011).
    [Show full text]
  • Plasma Membrane Integrity: Implications for Health and Disease Dustin A
    Ammendolia et al. BMC Biology (2021) 19:71 https://doi.org/10.1186/s12915-021-00972-y REVIEW Open Access Plasma membrane integrity: implications for health and disease Dustin A. Ammendolia1,2, William M. Bement3 and John H. Brumell1,2,4,5* Abstract Plasma membrane integrity is essential for cellular homeostasis. In vivo, cells experience plasma membrane damage from a multitude of stressors in the extra- and intra-cellular environment. To avoid lethal consequences, cells are equipped with repair pathways to restore membrane integrity. Here, we assess plasma membrane damage and repair from a whole-body perspective. We highlight the role of tissue-specific stressors in health and disease and examine membrane repair pathways across diverse cell types. Furthermore, we outline the impact of genetic and environmental factors on plasma membrane integrity and how these contribute to disease pathogenesis in different tissues. Keywords: Plasma membrane, Membrane damage, Lipid peroxidation, Pore formation, Membrane repair, Vesicle trafficking, Cell biology, Tissue injury, Disease Plasma membrane integrity signaling to shape the tissue environment. Alternatively, Confinement of a cell from its surrounding environment plasma membrane damage inflicted by microbial patho- is a universal trait of microscopic life. The plasma mem- gens and immune cells can have deleterious conse- brane fulfills this role whereby its integrity is vital for quences on cell fate during infection and inflammation cell function and survival. Accordingly, plasma mem- [4, 5]. The prevalence of membrane damage across func- brane architecture and composition varies to provide re- tionally distinct processes, from cell death to cancer cell sistance to injury in different cellular contexts.
    [Show full text]
  • Chronic Glomerulonephritis in Detail
    put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. [email protected] Chronic Renal Failure 8.03 Mr William Reynolds, a 62-year-old retired accountant presents with a six week history of lethargy and progressive ankle swelling. History of Presenting Illness - Most patients present with: Earliest : LETHARGY ANAEMIA - heavy proteinuria , FATIGUE - most commonly in the nephrotic range OEDEMA HYPOALBUMINAEMIA - insidious in onset. NOCTURIA Failure of CONCENTRATION ANOREXIA NAUSEA Early URAEMIA VOMITING INFECTIONS Early URAEMIA THROMBI PRURITIS BONE PAIN Renal OSTEOMALACIA or FRACTURE Latest: CONFUSION DEMENTIA Late URAEMIA COMA Differential Diagnoses - Acute renal failure - Inherited Clotting disorder - Liver failure - Gastrointestinal malignancy - Congestive heart failure - Acute glomerulonephritis - Hyperparathyroidism - Central Nervous System Lesion DIABETES Past History Hypertension Want to know about: systemic - LUPUS, and autoimmune disease in general infections, - Hypertension exposure to - History of renal disease in family drugs and toxins - CHEST PAIN Drugs of particular - EASY BRUISING Questions about uremia: importance - Recent Fractures - Appetite - analgesics - Shortness of Breath - Nausea/vomiting - NSAIDs , - SOB - Ankle Swelling - gold, - Oedema - Frequency of Nocturia - penicillamine, - Weight change - ? hematuria - Muscle cramps - vancomycin, - frothy urine - Bone pain - lithium, - Itching/scratching - Easy bruising - ACE inhibitors - Mental
    [Show full text]
  • How Does Proteinuria Cause Progressive Renal Damage?
    How Does Proteinuria Cause Progressive Renal Damage? Mauro Abbate,* Carla Zoja,* and Giuseppe Remuzzi*† *Mario Negri Institute for Pharmacological Research and †Unit of Nephrology and Dialysis, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy The possibility that proteinuria may accelerate kidney disease progression to end-stage renal failure has received support from the results of increasing numbers of experimental and clinical studies. Evidence indicating that this process occurs through multiple pathways, including induction of tubular chemokine expression and complement activation that lead to inflamma- tory cell infiltration in the interstitium and sustained fibrogenesis, is reviewed. Macrophages are prominent in the interstitial inflammatory infiltrate. This cell type mediates progression of renal injury to the extent that macrophage numbers in renal biopsy predict renal survival in patients with chronic renal disease. Chemoattractants and adhesive molecules for inflamma- tory cells are upregulated by excess ultrafiltered protein load of proximal tubular cells via activation of NF-␬B–dependent and NF-␬B–independent pathways. This mechanism is a potential target for therapeutic approaches, as shown by beneficial effects of manipulations with inhibitory molecules of NF-␬B activation or of chemokine receptors in experimental studies. Targeting complement synthesis or activation in proximal tubule might offer novel therapeutic opportunities. Finally, proximal tubular cell receptors for uptake of plasma proteins that are under investigation may provide activation signals on excess tubular protein handling. J Am Soc Nephrol 17: 2974–2984, 2006. doi: 10.1681/ASN.2006040377 he past 20 yr of research in nephrology have yielded and in patients who did not have diabetes and entered the substantial information on the mechanisms by which Modification of Diet in Renal Disease (MDRD) study (2).
    [Show full text]
  • Acceptable Macronutrient Distribution Ranges
    11 Macronutrients and Healthful Diets SUMMARY Acceptable Macronutrient Distribution Ranges (AMDRs) for indi- viduals have been set for carbohydrate, fat, n-6 and n-3 poly- unsaturated fatty acids, and protein based on evidence from interventional trials, with support of epidemiological evidence that suggests a role in the prevention or increased risk of chronic dis- eases, and based on ensuring sufficient intakes of essential nutrients. The AMDR for fat and carbohydrate is estimated to be 20 to 35 and 45 to 65 percent of energy for adults, respectively. These AMDRs are estimated based on evidence indicating a risk for coro- nary heart disease (CHD) at low intakes of fat and high intakes of carbohydrate and on evidence for increased risk for obesity and its complications (including CHD) at high intakes of fat. Because the evidence is less clear on whether low or high fat intakes during childhood can lead to increased risk of chronic diseases later in life, the estimated AMDRs for fat for children are primarily based on a transition from the high fat intakes that occur during infancy to the lower adult AMDR. The AMDR for fat is 30 to 40 percent of energy for children 1 to 3 years of age and 25 to 35 percent of energy for children 4 to 18 years of age. The AMDR for carbo- hydrate for children is the same as that for adults—45 to 65 percent of energy. The AMDR for protein is 10 to 35 percent of energy for adults and 5 to 20 percent and 10 to 30 percent for children 1 to 3 years of age and 4 to 18 years of age, respectively.
    [Show full text]
  • HIV and Renal Disorders Juliet Bennett Independent Nurse Advisor Abstract
    HIV Nursing 2017; 17: 77–87 Continuing professional development HIV and renal disorders Juliet Bennett Independent Nurse Advisor Abstract Despite advances in HIV medicine it is widely and monitoring of the condition. A range of acknowledged that people living with HIV (PLWH) are interventions are available to minimise further at particular risk of renal problems although the deterioration and to treat end-stage renal disease. pattern of disease has changed significantly over time. There is a clear role for nurses working in the field Renal disease, also known as kidney disease or of HIV alongside multidisciplinary colleagues in the nephropathy, is currently one of the most common provision of evidence-based screening and care for non-infectious comorbidities seen among PLWH. It is those affected, in order to improve clinical outcomes vital that health care professionals are aware of this and quality of life. risk in order to facilitate early detection, assessment Key words: renal disease, HIV, assessment, monitoring, treatment Introduction quiz before reading the article, returning to it afterwards to see how much you have learned.) enal disease was recognised as a complication of HIV infection soon after the disease itself was B. Aims and intended learning R identified in the early 1980s. As the natural outcomes history of HIV infection evolves, and with the ageing cohort (plus increased exposure to potentially This article aims to increase knowledge and nephrotoxic medications), prevalence of other non- confidence. On completion of reading, undertaking infectious comorbidities, such as diabetes and the included activities and self-assessment quiz you cardiovascular disease (CVD), renal disease in people should be able to: living with HIV (PLWH) is also increasing and growing ■ Describe the structure and function of the healthy in importance.
    [Show full text]
  • A High Protein Diet at the Upper End of the Acceptable
    A HIGH PROTEIN DIET AT THE UPPER END OF THE ACCEPTABLE MACRONUTRIENT DISTRIBUTION RANGE (AMDR) LEADS TO KIDNEY GLOMERULAR DAMAGE IN NORMAL FEMALE SPRAGUE-DAWLEY RATS BY ANDREW WAKEFIELD A Thesis Submitted to the Faculty of Graduate Studies of The University of Manitoba in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE Department of Human Nutritional Sciences University of Manitoba Winnipeg, Manitoba R3T 2N2 © August 2007 TABLE OF CONTENTS ACKNOWLEDGMENTS i ABSTRACT iii LIST OF TABLES v LIST OF FIGURES vi LIST OF ABBREVIATIONS x 1. INTRODUCTION AND RATIONALE FOR THESIS RESEARCH 1 1.1 Literature Review 3 1.1.1 Renal Disease Definition and Classification 3 1.1.2 Prevalence and Economic Cost 4 1.1.3 Prevalence Based on Stage 5 1.1.4 Treatment Based on Stage 7 1.1.5 Disease Assessment 7 1.2 Pathology and Pathophysiology of Renal Disease 9 1.2.1 The Glomerulus 9 1.2.2 Renal Disease Progression 10 1.3 Protein Restriction and Renal Disease 11 1.4 Prevalence of Obesity 12 1.5 Link between Obesity and Renal Disease: The Metabolic Syndrome 12 1.6 Weight Loss Strategies 13 1.6.1 Low-carbohydrate, HP diet 14 1.6.2 Theory behind the Diet 14 1.7 Effect of High Dietary Protein on the Normal Kidney 15 1.7.1 Human Studies on GFR 17 1.7.2 Long-term HP Diets and Rats 17 1.7.3 Rat Studies and Moderate Protein Levels 18 1.7.4 Long-term Human Studies and HP diets 19 1.8 Effect of High Dietary Protein in Mild Renal Insufficiency 20 1.9 Effect of High Dietary Protein in Renal Disease 21 1.10 Mechanisms of High Dietary Protein Intake on Progressive Renal Disease 22 1.11 Early Inflammatory Markers in Renal Disease 25 1.11.1 Nuclear Factor-κB 25 1.11.2 Transforming Growth Factor-Beta 1 28 1.11.3 Monocyte Chemoattractant Protein-1 28 1.11.4 Regulated upon Activation Normal T-cell Expressed and Secreted 29 1.11.5 Endothelin-1 29 1.12 Hypothesis and Objectives 30 2.
    [Show full text]